Dana D. Hu‐Lowe

Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor

Matthew R. Janes, Jingchuan Zhang, Lian‐Sheng Li et al. · Cell · 2018 · 1.1K citations · Full text

Kras Mutant Cancers, Medicine, Anti-cancer Agent +6

Rapid vascular regrowth in tumors after reversal of VEGF inhibition

Michael R. Mancuso, Rachel Davis, Scott M. Norberg et al. · Journal of Clinical Investigation · 2006 · 795 citations · Full text

Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling in Cancer Causes Loss of Endothelial Fenestrations, Regression of Tumor Vessels, and Appearance of Basement Membrane Ghosts

Tetsuichiro Inai, Michael R. Mancuso, Hiroya Hashizume et al. · American Journal Of Pathology · 2004 · 757 citations · Full text

Tumor Biology, Tumor Vessels, Angiogenesis +12

Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3

Dana D. Hu‐Lowe, Helen Y. Zou, Maren L. Grazzini et al. · Clinical Cancer Research · 2008 · 620 citations

Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling

Fabienne Baffert, Tom Le, Barbara Sennino et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2005 · 367 citations

Cellular Physiology, Vegf Inhibition, Normal Blood Capillaries +20